C/L/173. Intellectual Property Negotiation: GSK vs. Harbin
(2007, 3300 words)
This report has been produced to analyse the negotiations regarding the intellectual property rights agreement between GlaxoSmithKline, one of the leading research based pharmaceutical company and Harbin Pharmaceutical Group Holding Co. Ltd., a state holding Sino Foreign Joint Venture for the drug Cervarix TM, which is vaccine against human papillomavirus (HPV) that causes cervical cancer. The negotiations ended with GSK signing a 15 year contract with Harbin and approved for distribution in Australia in May 2007 for women aged 10 to 45
If you are ever dissatisfied with the services we
provide, we will try our very best to put the matter right. However, due to the nature of the products that are offered for
sale on this website, we have strict "no refund" policy.
All papers are for research and reference
purposes only! Copyright 2002-2008 Papers4You.Com All Rights Reserved.
Papers For You; Mile End Rd; London E1 4AQ UK